Mike Ouimette - 23 Jan 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Signature
/s/ Mike Ouimette
Issuer symbol
PLRX
Transactions as of
23 Jan 2023
Net transactions value
-$322,078
Form type
4
Filing time
25 Jan 2023, 20:00:46 UTC
Previous filing
23 Dec 2022
Next filing
27 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Options Exercise $118,600 +10,000 +168% $11.86 15,947 23 Jan 2023 Direct
transaction PLRX Common Stock Options Exercise $243,200 +10,000 +63% $24.32 25,947 23 Jan 2023 Direct
transaction PLRX Common Stock Sale $683,878 -20,000 -77% $34.19 5,947 23 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (right to buy) Options Exercise $0 -10,000 -11% $0.000000 77,000 23 Jan 2023 Common Stock 10,000 $11.86 Direct F2
transaction PLRX Stock Option (right to buy) Options Exercise $0 -10,000 -9.2% $0.000000 98,240 23 Jan 2023 Common Stock 10,000 $24.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022.
F2 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
F3 25% of the shares subject to such option vested on October 1, 2021 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.